-DOCSTART- -X- O
Developing -X- _ B-Patient
countries -X- _ I-Patient
face -X- _ O
unique -X- _ O
difficulties -X- _ O
preparing -X- _ O
for -X- _ O
an -X- _ O
influenza -X- _ O
pandemic. -X- _ O
Our -X- _ O
current -X- _ O
top-down -X- _ O
approach -X- _ O
will -X- _ O
not -X- _ O
provide -X- _ O
these -X- _ O
countries -X- _ O
with -X- _ O
adequate -X- _ O
supplies -X- _ O
of -X- _ O
vaccines -X- _ O
and -X- _ O
antiviral -X- _ O
agents. -X- _ O
Consequently -X- _ O
, -X- _ O
they -X- _ O
will -X- _ O
have -X- _ O
to -X- _ O
use -X- _ O
a -X- _ O
bottom-up -X- _ B-Intervention
approach -X- _ I-Intervention
based -X- _ I-Intervention
on -X- _ I-Intervention
inexpensive -X- _ I-Intervention
generic -X- _ I-Intervention
agents -X- _ I-Intervention
that -X- _ O
either -X- _ O
modify -X- _ O
the -X- _ O
host -X- _ O
response -X- _ O
to -X- _ O
influenza -X- _ O
virus -X- _ O
or -X- _ O
act -X- _ O
as -X- _ O
antiviral -X- _ O
agents. -X- _ O
Several -X- _ O
of -X- _ O
these -X- _ O
agents -X- _ O
have -X- _ O
shown -X- _ O
promise -X- _ O
, -X- _ O
and -X- _ O
many -X- _ O
are -X- _ O
currently -X- _ O
produced -X- _ O
in -X- _ O
developing -X- _ O
countries. -X- _ O
Investigators -X- _ O
must -X- _ O
primarily -X- _ O
identify -X- _ O
agents -X- _ O
for -X- _ O
managing -X- _ O
infection -X- _ O
in -X- _ O
populations -X- _ O
and -X- _ O
not -X- _ O
simply -X- _ O
seek -X- _ O
explanations -X- _ O
for -X- _ O
how -X- _ O
they -X- _ O
work. -X- _ O
They -X- _ O
must -X- _ O
determine -X- _ O
in -X- _ O
which -X- _ O
countries -X- _ O
these -X- _ O
agents -X- _ O
are -X- _ O
produced -X- _ O
and -X- _ O
define -X- _ O
patterns -X- _ O
of -X- _ O
distribution -X- _ O
and -X- _ O
costs. -X- _ O
Because -X- _ O
prepandemic -X- _ O
research -X- _ O
can -X- _ O
not -X- _ O
establish -X- _ O
whether -X- _ O
these -X- _ O
agents -X- _ O
will -X- _ O
be -X- _ O
effective -X- _ O
in -X- _ O
a -X- _ O
pandemic -X- _ O
, -X- _ O
randomized -X- _ O
controlled -X- _ O
trials -X- _ O
must -X- _ O
begin -X- _ O
immediately -X- _ O
after -X- _ O
a -X- _ O
new -X- _ O
pandemic -X- _ O
virus -X- _ O
has -X- _ O
emerged. -X- _ O
Without -X- _ O
this -X- _ O
research -X- _ O
, -X- _ O
industrialized -X- _ O
and -X- _ O
developing -X- _ O
countries -X- _ O
could -X- _ O
face -X- _ O
an -X- _ O
unprecedented -X- _ O
health -X- _ O
crisis -X- _ O
. -X- _ O

